Harvest Fund Management Co. Ltd bought a new position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 7,211 shares of the company's stock, valued at approximately $676,000.
Several other institutional investors and hedge funds have also bought and sold shares of CL. Deutsche Bank AG raised its holdings in Colgate-Palmolive by 35.6% during the fourth quarter. Deutsche Bank AG now owns 6,922,994 shares of the company's stock worth $629,369,000 after acquiring an additional 1,816,865 shares in the last quarter. Diamond Hill Capital Management Inc. increased its position in Colgate-Palmolive by 45.0% during the first quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company's stock worth $521,250,000 after buying an additional 1,727,105 shares during the last quarter. Castlekeep Investment Advisors LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth approximately $111,738,000. Renaissance Technologies LLC increased its position in Colgate-Palmolive by 70.2% during the fourth quarter. Renaissance Technologies LLC now owns 2,808,110 shares of the company's stock worth $255,285,000 after buying an additional 1,158,060 shares during the last quarter. Finally, GAMMA Investing LLC increased its position in Colgate-Palmolive by 10,601.7% during the first quarter. GAMMA Investing LLC now owns 1,105,379 shares of the company's stock worth $103,574,000 after buying an additional 1,095,050 shares during the last quarter. Institutional investors own 80.41% of the company's stock.
Colgate-Palmolive Stock Performance
Shares of Colgate-Palmolive stock traded down $0.34 on Friday, hitting $83.51. The stock had a trading volume of 9,606,667 shares, compared to its average volume of 4,420,865. Colgate-Palmolive Company has a twelve month low of $82.70 and a twelve month high of $109.30. The business's 50 day moving average is $89.59 and its two-hundred day moving average is $90.28. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96. The stock has a market cap of $67.68 billion, a price-to-earnings ratio of 23.59, a price-to-earnings-growth ratio of 4.32 and a beta of 0.37.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The firm's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.91 earnings per share. Analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's payout ratio is 58.76%.
Analyst Ratings Changes
A number of brokerages have weighed in on CL. JPMorgan Chase & Co. lowered their price target on Colgate-Palmolive from $103.00 to $99.00 and set an "overweight" rating on the stock in a research report on Friday, July 25th. UBS Group lowered their price target on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research report on Thursday, July 17th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Barclays boosted their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Finally, Citigroup boosted their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of "Hold" and an average price target of $100.58.
Check Out Our Latest Report on CL
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.